Toxicology and Environmental Health Sciences

, Volume 2, Issue 4, pp 278–283 | Cite as

Acetaminophen and its regioisomer, 3-acetamidophenol interfered with the growth ofEscherichia coli O157:H7

  • Mino Kang
  • SeongSoo A. An


Escherichia coli O157:H7 (O157) is an enterohemorrhagic pathogenic subtype, causing diarrhea and Hemolytic-uremic syndrome (HUS). Treatment for HUS patients might be accompanied with antibiotics and antispasmodics with analgesics for abdominal pain. Antiperistaltic effect of antispasmodics, however, may increase the risk of infection of O157 through the intestine. If analgesics also have antibacteiral effect, the prevention and cure of O157 could get benefits. Akhter, al. (2010) reported the inhibitory effect of ibuprofen (IBF) on the bacterial isolates from infected urinary tract. Here, we also found that acetaminophen (4-AAP) and its regioisomer, 3-acetamidophenol (3-AAP), constrained the growth of O157. Inhibitory effect was compared with IBF, since they were both COX inhibitors for their inhibitory mechanism. The experiment results showed that O157 growth was reduced in the presence of 4-AAP, 3-AAP, and IBF. Among them, the inhibitory effect of 4-AAP was less than 3-AAP and IBF in 1.8 fold at 10 mM concentrations. In addition, 4-AAP and 3-AAP inhibited the activity of endogenous peroxidase ofE. coli, as well as, horseradish peroxidase (HRP), implying its possible inhibitory mechanism. However, IBF did not inhibit peroxidase activity, suggesting the different mechanism to suppress the growth of O157 by 4-AAP and 3-AAP.


E. coli O157:H7 Acetaminophen 3′-hydroxyacetanilide Growth rate Inhibition 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Karmali, M. A. Infection by verocytotoxin-producingEscherichia coli. Clin. Microbiol. Rev. 2, 15–38 (1989).Google Scholar
  2. 2.
    Karmali, M. A. Infection by Shiga toxin-producingEscherichia coli: an overview.Mol. Biotechnol. 26, 117–122 (2004).PubMedCrossRefGoogle Scholar
  3. 3.
    Besser, R. al. An outbreak of diarrhea and hemolytic uremic syndrome fromEscherichia coli O157: H7 in fresh-pressed apple cider.JAMA. 269, 2217–2220 (1993).PubMedCrossRefGoogle Scholar
  4. 4.
    Ackers, M. al. An outbreak ofEscherichia coli O157:H7 infections associated with leaf lettuce consumption.J. Infect. Dis. 177, 1588–1593 (1998).PubMedCrossRefGoogle Scholar
  5. 5.
    Wong, C. al. The risk of the hemolytic-uremic syndrome after antibiotic treatment ofEscherichia coli O157:H7 infections.N. Engl. J. Med. 342, 1930–1936 (2000).PubMedCrossRefGoogle Scholar
  6. 6.
    Tarr, P. I., Gordon, C. A. & Chandler, W. L. Shigatoxin-producingEscherichia coli and haemolytic uremic syndrome.Lancet. 365, 1073–1086 (2005).PubMedGoogle Scholar
  7. 7.
    Tarr, P. I. & Neill, M. A.Escherichia coli O157:H7.Gastroenterol. Clin. North. Am. 30, 735–751 (2001).PubMedCrossRefGoogle Scholar
  8. 8.
    Hinz, B., Cheremina, O. & Brune, K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man.FASEB. J. 22, 383–390 (2008).PubMedCrossRefGoogle Scholar
  9. 9.
    García-Rodríguez, L. A. & Hernández-Díaz, S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs.Epidemiology.12, 570–576 (2001).PubMedCrossRefGoogle Scholar
  10. 10.
    Mielke, C. H. Jr. Comparative effects of aspirin and acetaminophen on hemostasis.Arch. Intern. Med. 141, 305–310 (1981).PubMedCrossRefGoogle Scholar
  11. 11.
    Catella-Lawson, al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.N. Engl. J. Med. 345, 1809–1817 (2001).PubMedCrossRefGoogle Scholar
  12. 12.
    James, L. P., Mayeux, P. R. & Hinson, J. A. Acetaminophen-induced hepatotoxicity.Drug. Metab. Dispos. 31, 1499–1506 (2003).PubMedCrossRefGoogle Scholar
  13. 13.
    Salminen, W. F. Jr., Voellmy, R. & Roberts, S. M. Differential heat shock protein induction by acetaminophen and a nonhepatotoxic regioisomer, 3′-hydroxyacetanilide, in mouse liver.J. Pharmacol. Exp. Ther. 282, 1533–1540 (1997).PubMedGoogle Scholar
  14. 14.
    Matthews, A. M., Hinson, J. A., Roberts, D. W. & Pumford, N. R. Comparison of covalent binding of acetaminophen and the regioisomer 3′-hydroxyacetanilide to mouse liver protein.Toxicol. Lett. 90, 77–82 (1997).PubMedCrossRefGoogle Scholar
  15. 15.
    An, S. S., Kim, M. G. & Chung, B. H. Detection ofEscherichia coli O157:H7 using its endogenous active membrane peroxidase.Submitted (2010).Google Scholar
  16. 16.
    Akhter, T., Baqai, R. & Aziz, M. Antibacterial effect of NSAIDS on clinical isolates of urinary tract infection and diabetic foot infection.Pak. J. Pharm. Sci. 23, 108–113 (2010).PubMedGoogle Scholar
  17. 17.
    Prescott, L. F., Roscoe, P., Wright, N. & Brown, S. S. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage.Lancet.1, 519–522 (1971).PubMedCrossRefGoogle Scholar
  18. 18.
    O’Malley, P. Too much of a good thing: paracetamol (acetaminophen) toxicity: update for the clinical nurse specialist.Clin. Nurse. Spec. 19, 18–19 (2005).PubMedCrossRefGoogle Scholar
  19. 19.
    Pappas, A. A., Taylor, E. H. & Ackerman, B. Toxicology and Drugs of Abuse, in: Howanitz, J., Howanitz, P. (Eds), Laboratory Medicine: Test Selection and Interpretation, New York, 382 (1991).Google Scholar
  20. 20.
    Nelson, E. B. Method for analgesia using 3-hydroxyacetanilide. US Patent 4238508. 9 Dec (1980).Google Scholar
  21. 21.
    Sakamoto, M. & Komagata, K. Aerobic growth of and activities of NADH oxidase and NADH peroxidase in lactic acid bacteria.J. Ferment. Bioeng. 82, 210–216 (1996).CrossRefGoogle Scholar
  22. 22.
    Condon, S. Responses of lactic acid bacteria to oxygen.FEMS Microbiol. Rev. 46, 269–280 (1987).CrossRefGoogle Scholar
  23. 23.
    Sakamoto, M., Uchimura, T. & Komagata, K. Comparison of H2O-forming NADH oxidase from Leuconostoc mesenteroides subsp. mesenteroides NRIC 1541T and H2O2-forming NADH oxidase from Sporolactobacillus inulinus NRIC 1133T.J. Ferment. Bioeng. 82, 531–537 (1996).CrossRefGoogle Scholar
  24. 24.
    Sakamoto, M., Tano, Y., Uchimura, T. & Komagata, K. Aerobic growth of some lactic acid bacteria enabled by the external addition of peroxidase (Horseradish) to the culture medium.J. Ferment. Bioeng. 85, 627–629 (1998).CrossRefGoogle Scholar

Copyright information

© The Korean Society of Environmental Risk Assessment and Health Science and Springer 2010

Authors and Affiliations

  1. 1.Department of Food Science and BiotechnologyKyungwon UniversityGyeonggiKorea
  2. 2.Department of Bionano TechnologyKyungwon UniversityGyeonggiKorea

Personalised recommendations